SynthesisPediatric surgery international2025
Postoperative antibiotic prophylaxis following pyeloplasty in children with ureteropelvic junction obstruction: evidence from a systematic review and meta-analysis.
Synthesis in Pediatric surgery international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUreteropelvic junction obstruction (UPJO) is a common pediatric urological anomaly often treated with pyeloplasty. Postoperative urinary tract infection (UTI) is a recognized complication, frequently prompting routine antibiotic prophylaxis despite limited evidence and growing concerns over antibiotic resistance. We aim to evaluate whether postoperative antibiotic prophylaxis reduces UTI incidence following pediatric pyeloplasty for UPJO.
methodsA systematic review and meta-analysis was conducted as per PRISMA guidelines (CRD42024550087). PubMed, Web of Science, Scopus, and EMBASE were searched (January 1990-May 2025) for relevant studies comparing postoperative antibiotic prophylaxis with no prophylaxis in children < 18 years undergoing pyeloplasty. Primary outcome was postoperative UTI incidence. Risk of bias was assessed using the Newcastle-Ottawa Scale for observational studies and RoB 2 for randomized trials. Pooled risk ratios (RR) with 95% confidence intervals (CI) were calculated using a random-effects model.
resultsFourteen studies (n = 3,587 patients; 3,589 pyeloplasties) were included; five provided comparative data for meta-analysis. Postoperative prophylaxis was administered in 67.3% of cases. The overall incidence of UTI in the prophylaxis group was 8.7%. Meta-analysis (five studies; n = 2,279) showed no significant difference in UTI incidence between the two groups (RR 1.19, 95% CI 0.92-1.56; p = 0.19; I²=0%). Most pyeloplasties (91.5%) involved double-J stents, typically removed within 4-6 weeks. Data on antibiotic type, regimen, and duration were variably reported.
conclusionsPostoperative antibiotic prophylaxis after pediatric pyeloplasty does not significantly reduce UTI incidence. These findings support reconsideration of blanket antibiotic use in favour of targeted prophylaxis, such as peri-procedural coverage at stent removal, aligning with antibiotic stewardship principles. Limited data precluded analysis of potentially influential factors, including stent type/duration, antibiotic regimen, and surgical approach. Future well-designed studies should address these gaps to optimize prophylaxis strategies.
Indexed as
Identifiers
41160196What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.